DrugCombination product
Isoascorbic acid clinical trials
A product of Ascorbic Acid; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
Memorial Sloan Kettering Cancer Center (1) · Merck Sharp & Dohme LLC (1) · Nazarbayev University (1) · Jonsson Comprehensive Cancer Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses isoascorbic acid is read from its arms, and is right about nine times in ten.
Testing it · 4
- Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal CancerStatus unknownPhase 1/2Nazarbayev UniversityNCT05721872Written as D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO)
- Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)TerminatedPhase 2Merck Sharp & Dohme LLCNCT01381666Written as INS316 solution for inhalation
- INS316 Compared With Saline for Sputum Collection in Diagnosing Lung CancerStatus unknownNot applicableJonsson Comprehensive Cancer CenterNCT00033527Written as INS316
- INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00008255Written as INS316
Codes
What other systems call isoascorbic acid · ClinicalTrials.gg INT002312
- MeSH (NLM) C005056isoascorbic acidOne source NLM
- UNII (FDA) 311332OII1ERYTHORBIC ACIDConfirmed FDA, NLM
- RxNorm 1356145One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C005056 | isoascorbic acid | One source NLM |
| UNII (FDA) | 311332OII1 | ERYTHORBIC ACID | Confirmed FDA, NLM |
| RxNorm | 1356145 | — | One source FDA |
Also registered as sodium erythorbate (UNII BZ468R6XRD).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.